Interventions for melanoma in situ, including lentigo maligna

  • Protocol
  • Intervention

Authors

  • Zoe Apalla,

    Corresponding author
    1. Hospital of Skin and Venereal Diseases, State Clinic of Dermatology, Thessaloniki, Greece
    • Zoe Apalla, State Clinic of Dermatology, Hospital of Skin and Venereal Diseases, 17, Omirou street, Thessaloniki, 55535, Greece. zoimd@yahoo.gr.

    Search for more papers by this author
  • Thrasivoulos Tzellos,

    1. Faculty of Health Sciences, University Hospital of Northern Norway, Department of Dermatology, Harstad, Troms, Norway
    Search for more papers by this author
  • Athanassios Kyrgidis,

    1. Dessau Medical Center, Division of Evidence Based Dermatology, Dessau, Germany
    2. Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Dermatology and Skin Cancer Unit, Arcispedale Santa Maria Nuova, Reggio Emilia, Italy
    3. Aristotle University of Thessaloniki, Otolaryngology Head & Neck Surgery, Thessaloniki, Greece
    Search for more papers by this author
  • Simone Mocellin,

    1. University of Padova, Meta-Analysis Unit, Department of Surgery, Oncology and Gastroenterology, Padova, Veneto, Italy
    Search for more papers by this author
  • An-Wen Chan,

    1. University of Toronto, Women's College Research Institute, Toronto, ON, Canada
    Search for more papers by this author
  • Shaheen Haque Hussain,

    1. Addenbrooke's Hospital, Department of Dermatology, Cambridge, UK
    Search for more papers by this author
  • Pierluigi Pilati

    1. University of Padova, Meta-Analysis Unit, Department of Surgery, Oncology and Gastroenterology, Padova, Veneto, Italy
    Search for more papers by this author

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To assess the effects of all available interventions, surgical and non-surgical, for the treatment of melanoma in situ, including lentigo maligna. We also aim to assess efficacy, harms, and tolerability of postoperative adjuvant therapies after surgical treatment, as well as the efficacy, harms, and tolerability of non-surgical interventions preoperatively (neoadjuvant therapies), in order to facilitate surgical removal.

Ancillary